Abstract

Comorbidity substantially affects breast cancer risk and prognosis. However, women with chronic conditions are less likely to participate in mammography screening. Few studies have examined potential benefits of mammography in women with chronic conditions. This study investigated the moderation effects of mammography screening on early stage breast cancer and all-cause mortality among women aged 50–69 years with chronic conditions in Taiwan. We used a matched cohort design with four nationwide population databases, and an exact matching approach to match groups with different chronic conditions. Women population aged 50–69 years in 2010 in Taiwan were studied. A generic Charlson comorbidity index (CCI) measure was used to identify chronic illness burden. The sample sizes of each paired matched group with CCI scores of 0, 1, 2, or 3+ were 170,979 using a 1-to-1 exact matching. Conditional logistic regressions with interaction terms were used to test moderation effect, and adjusted predicted probabilities and marginal effects to quantify average and incremental chronic conditions associated with outcome measures. Statistical analyses were conducted in 2020–2021. Women with more chronic conditions were less likely to participate in mammography screening or to receive early breast cancer diagnoses, but were at greater risk of mortality. However, mammography participation increased the likelihood of early breast cancer diagnosis (OR 1.48, 95% CI 1.36–1.60) and decreased risk of all-cause mortality (HR 0.53, 95% CI 0.51–0.55). The interaction terms of CCI and mammography participation indicated significantly increased benefits of early breast cancer diagnosis and decreased risk of all-cause mortality as chronic illness increased. Mammography participation significantly moderated the link between comorbidity and outcome measures among women with chronic conditions. Hence, it is important for public health policy to promote mammography participation for women with multiple chronic conditions.

Highlights

  • Comorbidity substantially affects breast cancer risk and prognosis

  • Report from the 2013 National Health Interview Survey of America found that 69.1% of women aged 50 years or older are adherent to breast cancer screening guidelines every 2 years, while but mammography screening rates remain much lower in Asian c­ ountries[3]

  • After exact matching based on index age and income status, demographic characteristics among women at different Charlson comorbidity index (CCI) levels were comparable

Read more

Summary

Introduction

Comorbidity substantially affects breast cancer risk and prognosis. women with chronic conditions are less likely to participate in mammography screening. This study investigated the moderation effects of mammography screening on early stage breast cancer and all-cause mortality among women aged 50–69 years with chronic conditions in Taiwan. Demb et al used mammography registry data to examine the effects of continuous mammography on risk of incident breast cancer and mortality among 222,088 screened women ages greater than 66 years old in the United States, and found older women with increasing comorbidity may have diminished benefit from continuous ­screening[13]. There were still lack of nationwide population-based studies examining the magnitude of potential interaction effect between mammography uptake and chronic conditions on early detection or health outcomes

Objectives
Methods
Results
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call